Offer - Urjas Oil for just ₹ 1 X
Erlokem is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Pancreatic Cancer, Non-Small Cell Lung Cancer.
Medical history of the patient along with age and gender determines the dosage of Erlokem. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Erlokem have been listed ahead. Normally, these side effects of Erlokem are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Erlokem's effect is Moderate during pregnancy and Moderate for lactating mothers. Further, the section on Erlokem related warnings talks about Erlokem's effects on the liver, heart and kidney.
Erlokem is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease, Kidney Disease, Lung Disease are examples of such conditions. Some other conditions that can be affected by Erlokem are listed in the contraindications section below.
Besides this, Erlokem may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to the above precautions for Erlokem, it is important to know that it is not safe while driving, and is not habit-forming.
Erlokem is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Erlokem safe for pregnant women?
Erlokem may have some side effects during pregnancy. Pregnant women should discontinue the use of Erlokem, and talk to their doctor, if they notice any discomfort.
Is the use of Erlokem safe during breastfeeding?
Breastfeeding women may feel side effects of Erlokem. If you see any side effects, stop taking Erlokem immediately and talk to your doctor. Take Erlokem again, only after your doctor's advice.
What is the effect of Erlokem on the Kidneys?
Erlokem is completely safe for kidneys.
What is the effect of Erlokem on the Liver?
Erlokem can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Erlokem on the Heart?
You can take Erlokem without any fear of damage to the heart.
Erlokem should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Erlokem unless your doctor advises you to do so -
Is this Erlokem habit forming or addictive?
Forming a habit of Erlokem has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Erlokem, you should not drive or work on any heavy machine, as Erlokem can make you drowsy.
Is it safe?
Erlokem should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Erlokem is not used to treat mental disorders.
Interaction between Food and Erlokem
Some foods when eaten with Erlokem can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Erlokem
Information about the interaction of Erlokem and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tarceva® (erlotinib)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 870
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 514-516